Iowa Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.

Press releases published on November 4, 2026

Nov. 4, 2026

Mineralys Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 4, 2026

OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire

Nov. 4, 2026

LeMaitre Q3 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Nov. 4, 2026

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates

Indeterminate GlobeNewswire

Nov. 4, 2026

Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Larimar Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 4, 2026

Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

Indeterminate GlobeNewswire

Nov. 4, 2026

electroCore Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Myriad Genetics Reports Third Quarter 2026 Financial Results; Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution Definitive Agreement to Sell Prenatal Health Business to Support Strategic Growth Initiatives

Indeterminate GlobeNewswire

Nov. 4, 2026

Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Alamar Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 4, 2026

Pennant Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 4, 2026

BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance

Indeterminate GlobeNewswire

Nov. 4, 2026

Medicus Pharma to Host Third Quarter 2026 Financial Performance and Business Update Call on November 9, 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Baird Medical Issues Statement Regarding Recent Share Price Volatility

Indeterminate GlobeNewswire

Nov. 4, 2026

Revolution Medicines Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire